Latest Articlesddd
Compugen Compugen (CGEN) cancer immunotherapy’s predictive target computational discovery platforms enabled it to identify two checkpoint …
Inovio Inovio’s COVID-19 Vaccine INO-4800 Accomplished the Following: Durable antibody and T cell responses in rhesus …
Edesa Biotech Filed an IND for EB05 Edesa Biotech (EDSA), a clinical-stage biopharmaceutical company, has filed …
SARS-CoV-2 Virus Vaccines Moderna On Monday Moderna (MRNA) started its Phase 3 clinical trial on 30,000 …
Gilead Sciences CAR T Cell Product Tecartus Gets FDA Approval The U.S. FDA approved Kite - …
TCR2 Therapeutics Announcement TCR2 Therapeutics (TCRR) – a clinical-stage immunotherapy company with a pipeline of novel T cell therapies …
Arbutus Biopharma and Moderna's Patent Challenge Arbutus Biopharma (ABUS) is a publicly-traded biopharmaceutical company dedicated to …
People living with narcolepsy who develop cataplexy and excessive daytime sleepiness have a new treatment called Xywav, …
Firms' with COVID-19 Vaccines Stock Performance A look at the stock performance of the COVID-19 vaccine …
Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the …
Alzheimer’s Disease Alzheimer’s Disease has proven very difficult to treat through many of the trials’ attempts …
Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase …
CRiSPR Therapeutics Rally For those who wonder why CRiSPR Therapeutics (CRSP) is soaring we remind that …
Corvus Pharmaceuticals: FDA Granted IND Application for COVID-19 Trial The United States FDA granted approval of Corvus …
Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …
Akero Therapeutics Today we posted good news from Akero Therapeutics (AKRO) under News & Comments. The …
Akero Therapeutics Efruxifermin Positive Results in NASH Akero Therapeutics (AKRO) results of a 16-week analysis of secondary …
Unclear Reasoning for the Inovio Selloff Though Inovio (INO) announced positive interim clinical data of INO-4800 …
A Letter to Subscribers The complex brutal circumstances we are currently living in has made it …
Novel Coronavirus Vaccines and Wall Street Vaccines against novel coronavirus are recognized now as the only …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
